柳叶刀_2012-May-12.pdf
Articles ofUlm, Ulm, Germany showed no benefit of Stanford-V over ABVD.- By were recruited and treated inhospitals and practices jo uawμedag:(GW auq0O H) contrast, BEACOPPeas resulted in improved tumour in Germany, the Czech Republic, Switzerland, The Haematology and Oncology, Charite-Campus Vi
Articles 8xBEACOPP 6xBEACOPP 8xBEACOPP Results(N=705)(N=711)(N=710)patients were randomly assigned to treatment Acute toxicity(WHO grade 3 or 4)* groups between Jan 28,2003, and April 18, 2008.At least one event 658/684(962) 671/696(96-4) 619/693(893)patients were excluded fro
Articles This analysis showed that patients in partial remission A with a PET-negative persistent mass after chemotherapy 1- 6xB 8xB 8xB had a prognosis very similar to those in complete 09- remission as measured by conventional CT(4year progression-free survival of 921)8 - 0. 
